BOSTON, April 16, 2019 /PRNewswire/ -- Parabricks Inc. (www.parabricks.com), announced today their collaboration with Google Cloud as a Technology Partner,...
DALLAS, April 17, 2019 /PRNewswire/ -- DoctorLogic, the official website partner of the AACD, will be attending the 2019 AACD...
76% of respondents believe it is a major issueLondon, U.K., 17 April, 2019 – The latest Bellwether research paper titled,...
Company Receives 3rd Communique from FDA for Clearance of its GenChoice Test Strip, and at the Request of Agent Paragon,...
KING OF PRUSSIA, PA / ACCESSWIRE / April 17, 2019 / Emergent Health Corp. (the "Company") purpose of this Press...
Newly Issued Patent Strengthens Accuracy of TAEUS Fat Quantification Methodologies ANN ARBOR, MI / ACCESSWIRE / April 17, 2019 /...
VANCOUVER, BC / ACCESSWIRE / April 17, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) is moving rapidly...
Extensive Intellectual Property Portfolio Now Includes 149 Patents and Applications REDWOOD CITY, CA / ACCESSWIRE / April 17, 2019 /...
KINDERHOOK, NY / ACCESSWIRE / April 16, 2019 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results...
PORTLAND, OR / ACCESSWIRE / April 16, 2019 / For thousands of Oregonians and their families, a diagnosis of autism...
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 16, 2019 / Brighthaven Ventures LLC. ("BHV"), a wholly owned subsidiary of...
OFFENBACH, GERMANY / ACCESSWIRE / April 16, 2019 / Prostate cancer is the most common cancer in men, affecting 25%...
Virpax® to Develop a Non-Opioid Molecular Envelope Technology (MET) Intranasal Formulation for the Management of Chronic Pain MALVERN, PA /...
SAN MATEO, CA / ACCESSWIRE / April 16, 2019 / Allysta Pharmaceuticals, Inc. ("Allysta") today announced that they have completed...
ENGLEWOOD, CO / ACCESSWIRE / April 16, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on...
Funding strengthens CEVEC's leading role in viral vector manufacturing technology CEVEC's technology allows for industrial scale manufacturing of AAV vectors...
BALTIMORE, MD / ACCESSWIRE / April 15, 2019 / AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing vital new...
TORONTO, ON / ACCESSWIRE / April 15, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) (''Intellipharmaceutics'' or the...
Expansion brings expertise on Alzheimer's Disease and other neurodegenerative diseases to the SAB ALACHUA, FL / ACCESSWIRE / April 15,...
93% Primary Patency Rate and 100% Freedom from Target Lesion Revascularization at 12 Months REDWOOD CITY, CA / ACCESSWIRE /...